BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20208138)

  • 1. Pre T-cell receptor alpha (pTalpha) expression patterns and functional analysis in human T-cell lymphoblastic leukemia.
    Ivanyi P; Morgan M; Piao W; Ukena SN; Steube K; Ganser A; Franzke A
    Cell Oncol; 2010; 32(1-2):101-8. PubMed ID: 20208138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
    Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-cell leukemia virus type 1 Tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytes.
    Wencker M; Sausse C; Derse D; Gazzolo L; Duc Dodon M
    J Virol; 2007 Jan; 81(1):301-8. PubMed ID: 17050604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC-restricted T cell receptor signaling is required for alpha beta TCR replacement of the pre T cell receptor.
    Croxford AL; Akilli-Ozturk O; Rieux-Laucat F; Förster I; Waisman A; Buch T
    Eur J Immunol; 2008 Feb; 38(2):391-9. PubMed ID: 18203137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.
    De Keersmaecker K; Porcu M; Cox L; Girardi T; Vandepoel R; de Beeck JO; Gielen O; Mentens N; Bennett KL; Hantschel O
    Haematologica; 2014 Jan; 99(1):85-93. PubMed ID: 23872305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.
    Laukkanen S; Veloso A; Yan C; Oksa L; Alpert EJ; Do D; Hyvärinen N; McCarthy K; Adhikari A; Yang Q; Iyer S; Garcia SP; Pello A; Ruokoranta T; Moisio S; Adhikari S; Yoder JA; Gallagher K; Whelton L; Allen JR; Jin AH; Loontiens S; Heinäniemi M; Kelliher M; Heckman CA; Lohi O; Langenau DM
    Blood; 2022 Oct; 140(17):1891-1906. PubMed ID: 35544598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoH modulates pre-TCR and TCR signalling by regulating LCK.
    Wang H; Zeng X; Fan Z; Lim B
    Cell Signal; 2011 Jan; 23(1):249-58. PubMed ID: 20851766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
    Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
    Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
    Krystal GW; DeBerry CS; Linnekin D; Litz J
    Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential subcellular localization regulates c-Cbl E3 ligase activity upon Notch3 protein in T-cell leukemia.
    Checquolo S; Palermo R; Cialfi S; Ferrara G; Oliviero C; Talora C; Bellavia D; Giovenco A; Grazioli P; Frati L; Gulino A; Screpanti I
    Oncogene; 2010 Mar; 29(10):1463-74. PubMed ID: 19966856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and pharmacological evaluation of novel benzothiazole derivatives targeting LCK in acute lymphoblastic leukemia.
    Chen Y; Zhang K; Tan J; Fan Z; Fu Y; Li X; Liu B; Wang G
    Bioorg Chem; 2024 Mar; 144():107180. PubMed ID: 38335758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch3 and pTalpha/pre-TCR sustain the in vivo function of naturally occurring regulatory T cells.
    Campese AF; Grazioli P; Colantoni S; Anastasi E; Mecarozzi M; Checquolo S; De Luca G; Bellavia D; Frati L; Gulino A; Screpanti I
    Int Immunol; 2009 Jun; 21(6):727-43. PubMed ID: 19461123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs.
    Gruber C; Henkel M; Budach W; Belka C; Jendrossek V
    Biochem Pharmacol; 2004 May; 67(10):1859-72. PubMed ID: 15130763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage-specific control of superantigen-induced cell death by the protein tyrosine kinase p56(lck).
    Penninger JM; Wallace VA; Molina T; Mak TW
    J Immunol; 1996 Dec; 157(12):5359-66. PubMed ID: 8955183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
    Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
    Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.
    Vahedi S; Chueh FY; Dutta S; Chandran B; Yu CL
    Oncol Rep; 2015 Jul; 34(1):43-50. PubMed ID: 25997448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2A and HEB activate the pre-TCR alpha promoter during immature T cell development.
    Takeuchi A; Yamasaki S; Takase K; Nakatsu F; Arase H; Onodera M; Saito T
    J Immunol; 2001 Aug; 167(4):2157-63. PubMed ID: 11490000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia.
    Harr MW; Caimi PF; McColl KS; Zhong F; Patel SN; Barr PM; Distelhorst CW
    Cell Death Differ; 2010 Sep; 17(9):1381-91. PubMed ID: 20300113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM1 controlled lateral segregation of tyrosine kinase Lck predispose T-cells to cell-derived galectin-1-induced apoptosis.
    Novák J; Kriston-Pál É; Czibula Á; Deák M; Kovács L; Monostori É; Fajka-Boja R
    Mol Immunol; 2014 Feb; 57(2):302-9. PubMed ID: 24231767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues.
    Nyakeriga AM; Garg H; Joshi A
    Cytometry A; 2012 Sep; 81(9):797-805. PubMed ID: 22674786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.